Access cutting-edge macular degeneration treatment through this clinical trial at a research site in Bakersfield. Study-provided care at no cost to qualified participants.
Access macular degeneration specialists in Bakersfield at no cost
This study follows strict safety protocols and ethical guidelines
All study-related macular degeneration treatment provided free
This study will evaluate the long-term safety and tolerability of the Port Delivery System with ranibizumab (PDS) (100 mg/mL) in participants with neovascular age-related macular degeneration (nAMD) who have either completed Phase II Study GX28228 (Ladder), Phase III Study GR40548 (Archway), Phase IIIb Study WR42221 (Velodrome), or completed Week 24 visit in Study WR42221 but were not eligible to be randomized in WR42221.
Sponsor: Hoffmann-La Roche
Check if you qualify for this macular degeneration clinical trial in Bakersfield, CA
If you're searching for macular degeneration treatment options in Bakersfield, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Bakersfield research site is actively enrolling participants for this clinical trial. You'll receive care from experienced macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.